BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Biotech Beach

  Oculus Innovative Sciences, Inc. Reports Fiscal Fourth Quarter 2012 Financial Results

  June 8, 2012

   · 

  1 min read
• Allenex AB: University of Miami Initiates Clinical Trial of XM-ONE®

  June 8, 2012

   · 

  1 min read
• Genetown

  Publicity Club of New England Presents Dana-Farber Cancer Institute with $2,000 Check

  June 8, 2012

   · 

  1 min read
• Mesoblast Limited Provides Corporate Strategy for Product Development to Treat Neurologic Conditions

  June 8, 2012

   · 

  1 min read
• Pharm Country

  CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)

  June 8, 2012

   · 

  3 min read
• Pharm Country

  Morgan Technical Ceramics Showcased Innovative Medical Ceramic Materials, Components and Assemblies at MD&M East 2012

  June 8, 2012

   · 

  4 min read
• Genetown

  N.Y. Senator to SEC: Probe Vertex Pharmaceuticals Incorporated Stock Sales

  June 8, 2012

   · 

  1 min read
• Pharm Country

  Johnson & Johnson Diabetes Drug Seen Challenging Merck & Co., Inc.'s Market Leader

  June 8, 2012

   · 

  1 min read
• Policy

  Novo Nordisk A/S Hit By US Delay to New Insulin Drug

  June 8, 2012

   · 

  1 min read
• Drug Development

  PTC Therapeutics, Inc. Release: Top-line Data From Phase 3 Trial of Ataluren in Patients with Nonsense Mutation Cystic Fibrosis Show Promising Results

  June 8, 2012

   · 

  8 min read